N/A
Completed N=385
Improving Colorectal Cancer Screening in Racially Diverse Zip Codes Using Navigation and Machine Learning (PCSNaP)
Source: ClinicalTrials.gov NCT05383976 ↗Enrolled (actual)
385
Serious AEs
—
Results posted
Feb 2026
Primary outcomePrimary: Enrollment in Navigator Program (Feasibility) — 79 Participants
Summary
The overarching goal of the "PCSNaP" Research Study is to support the Abramson Cancer Center (ACC) of the University of Pennsylvania in carrying out its mission to increase colorectal cancer (CRC) screening completion among high-risk individuals living in a persistent poverty county by designing, conducting, disseminating and evaluating an electronic health record-based automated identification program to target effective, culturally-sensitive CRC screening navigation to individuals who have not completed an ordered colonoscopy or fecal immunochemical test (FIT).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Enrollment in Navigator Program (Feasibility) |
79 | — |
| PRIMARY Completion of Colorectal Cancer Screening |
92; 79 | — |
| PRIMARY Number of Participants With Adenoma Detection |
21; 15 | — |
Eligibility Criteria
Inclusion Criteria
- Patients residing in 18 zip codes in Western and Southwestern Philadelphia who have primary care providers in 4 Penn Medicine Internal Medicine practices and 3 Penn Medicine Family Medicine Practices
- Patients who have had a colonoscopy order placed in the past 6 months and have not scheduled, cancelled, or no-showed to their colonoscopy
Exclusion Criteria
- Not applicable
Data sourced from ClinicalTrials.gov (NCT05383976). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.